Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0605
E

Failure to Ensure Gradual Dose Reductions and Timely Review of Antipsychotic Medications

Wakefield, Nebraska Survey Completed on 07-22-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that residents' drug regimens were free from unnecessary psychotropic medications, specifically antipsychotics, as required by both facility policy and federal regulations. For two residents with dementia and behavioral disturbances, the facility did not attempt or document Gradual Dose Reductions (GDRs) for their prescribed Seroquel, despite these residents having been on the medication since admission. The care plans and medication administration records for these residents showed ongoing use of antipsychotic medication without evidence of GDRs being addressed or attempted over the previous year. The Director of Nursing confirmed that no GDRs had been attempted or documented for these residents during this period. Additionally, another resident with severe cognitive impairment and multiple diagnoses, including dementia, heart disease, anxiety, and depression, was prescribed Haldol as needed for agitation, aggression, or restlessness. The as-needed order for Haldol was continued and administered beyond the 14-day limit without documented evaluation by the primary care provider for appropriateness, as required by facility policy. The Director of Nursing confirmed that the medication was administered past the 14-day limit. These actions were inconsistent with the facility's own policy and regulatory requirements regarding the use and review of psychotropic medications.

An unhandled error has occurred. Reload 🗙